HSE - Important information about the generation of Active Bromine in Great Britain (GB) - 8/2/24
![Blog Image](https://www.wmsoc.org.uk/storage/news/sml-625.jpg)
Industry has had the opportunity to support biocidal active substances – including those generated in-situ – for a safety and efficacy review for the relevant product types. The GB BPR groups biocidal products into 22 product types dependent on their use.
For a number of combinations of precursors used to generate Active Bromine, industry decided to withdraw their support for the necessary reviews.
An opportunity was provided for any person, company or task force/consortium to take over support for the biocidal active substance/product type combinations in the GB BPR Review Programme. However, HSE did not receive any compliant notifications from industry to continue their support for:
In cases where active substance/product type combinations are not supported, GB BPR requires that these active substance/product type combinations are subject to a GB non-approval decision.
When an active substance receives a non-approval decision, biocidal products containing these active substances in the relevant product types will have to be removed from the GB market, and biocidal use of the in-situ generated active substance will have to end. HSE will provide separate updates on the decision and relevant phase-out periods.
After the relevant phase out period these biocidal products will not be able to be supplied or used in GB.
Important: If you are aware of any disproportionate negative effects that are likely to arise as a result of the Active Bromine generation methods and uses listed above being removed from the GB market, please contact us by 8 March 2024.
There are other precursor combinations that can still be used to generate Active Bromine. For more information please see our BPR list of active substances